Monoamine oxidases (MAOs) serve a crucial function in the regulation of mood and behavior. Flavin-containing MAOs catalyze the oxidative deamination of both dietary and neuroactive monoamines, generating the byproduct hydrogen peroxide (H2O2). The two MAO isoenzymes, MAO A and (SSRIs). However, the development of reversible inhibitors of MAO A (RIMAs), which have proven effective in treatment-resistant and atypical depression, may spur the development of novel MAO inhibitors with enhanced safety and effectiveness.
Reference:Timothy M. Darden. USE OF MONOAMINE OXIDASE AND REDOX ENZYMESIN ATRIAL TISSUE AS NOVEL PREDICTORS OF POSTOPERATIVE ATRIAL FIBRILLATION
Products for Monoamine Oxidase